The Cell and Gene Therapy Catapult (CGT Catapult), German CDMO Rentschler Biopharma and mass photometry pioneer Refeyn Ltd (Oxford), are combining their expertise in manufacturing and process analytical technologies (PAT) to improve the efficiency of adeno-associated viruses (AAV) manufacture. Click to read more.